VitaSpring Biomedical Co (VSBC) Total Assets by Year
VitaSpring Biomedical Co closed fiscal year 2026 with $15K in total assets, $4.4M in total liabilities and -$4.4M in shareholder equity. Total assets rose 2.1% from the prior fiscal year. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters VitaSpring Biomedical Co has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VSBC Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $15K+2.1% | $14K-89.5% | $137K-82.1% | $766K-78.7% | $3.6M+1802.9% | $189K0.0% | $189K+4097.7% | $5K+140.8% | $2K-75.0% | $8K |
| Total Liabilities | $4.4M+10.3% | $4.0M+15.5% | $3.5M+10.3% | $3.2M+56.1% | $2.0M+2078.3% | $93K-50.9% | $189K+1556.9% | $11K+116.0% | $5K+16.2% | $5K |
| Total Equity | -$4.4Mn/m | -$4.0Mn/m | -$3.4Mn/m | -$2.4M-251.9% | $1.6M+1537.1% | $96Kn/m | $0n/m | -$7Kn/m | -$3K-215.7% | $3K |
VSBC Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $15K-12.9% | $11K-4.0% | $15K+2.1% | $16K-71.8% | $17K-73.5% | $12K-90.9% | $14K-89.5% | $58K-78.9% | $64K-84.1% | $131K-76.1% | $137K-82.1% | $277K-88.6% |
| Total Liabilities | $4.7M+10.7% | $4.5M+10.0% | $4.4M+10.3% | $4.4M+11.1% | $4.2M+12.1% | $4.1M+12.3% | $4.0M+15.5% | $3.9M+14.1% | $3.8M+11.6% | $3.7M+14.0% | $3.5M+10.3% | $3.4M+352.0% |
| Total Equity | -$4.7Mn/m | -$4.5Mn/m | -$4.4Mn/m | -$4.3Mn/m | -$4.2Mn/m | -$4.1Mn/m | -$4.0Mn/m | -$3.9Mn/m | -$3.7Mn/m | -$3.5Mn/m | -$3.4Mn/m | -$3.2M-288.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More VitaSpring Biomedical Co financials
Frequently Asked Questions
VitaSpring Biomedical Co closed fiscal year 2026 with $15K in total assets, $4.4M in total liabilities and -$4.4M in shareholder equity.
VitaSpring Biomedical Co (VSBC) total assets rose by 2.1% year over year, from $14K to $15K in fiscal year 2026.
Across the 10 fiscal years this page covers, VitaSpring Biomedical Co (VSBC) total assets went from $8K in fiscal year 2017 to $15K in fiscal year 2026.
VitaSpring Biomedical Co (VSBC) reported $15K in total assets in Q2 2027. This represents a decrease of 12.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what VitaSpring Biomedical Co (VSBC) reported on that line in every period on record.